Tuesday, April 30, 2019

FDA approves first treatment for all genotypes of hepatitis C in pediatric patients - FDA Press Releases

FDA approved Mavyret (glecaprevir and pibrentasvir) tablets to treat all six genotypes of hepatitis C virus (HCV) in children ages 12 to 17.

from FDA Press Releases RSS Feed http://bit.ly/2WaHKWB
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)